John Northcott
2021
In 2021, John Northcott earned a total compensation of $3.8M as Senior Vice President and Chief Commercial Officer at Nektar Therapeutics, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $388,125 |
|---|---|
| Option Awards | $998,320 |
| Salary | $675,000 |
| Stock Awards | $1,707,078 |
| Other | $7,950 |
| Total | $3,776,473 |
Northcott received $1.7M in stock awards, accounting for 45% of the total pay in 2021.
Northcott also received $388.1K in non-equity incentive plan, $998.3K in option awards, $675K in salary and $8K in other compensation.
Rankings
In 2021, John Northcott's compensation ranked 3,527th out of 12,405 executives tracked by ExecPay. In other words, Northcott earned more than 71.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,527 out of 12,405 | 72nd |
Division Manufacturing | 1,445 out of 5,494 | 74th |
Major group Chemicals And Allied Products | 584 out of 2,369 | 75th |
Industry group Drugs | 521 out of 2,090 | 75th |
Industry Pharmaceutical Preparations | 364 out of 1,537 | 76th |
Source: SEC filing on April 29, 2022.
Northcott's colleagues
We found four more compensation records of executives who worked with John Northcott at Nektar Therapeutics in 2021.